FisclearFisclear

Financial Comparison

Sun Pharmaceutical Industries Limited vs Torrent Pharmaceuticals Limited

Click a ticker to view the full analysis.

SUNPHARMA.NS vs

In short

Sun Pharmaceutical Industries Limited is the more profitable of the two, keeping 19.7% of revenue as net profit against 15.7% for Torrent Pharmaceuticals Limited. Torrent Pharmaceuticals Limited trades at the higher trailing P/E (72.5× vs 35.2× for Sun Pharmaceutical Industries Limited), so investors pay more for each dollar of its earnings. Fisclear flags 0 medium- or high-severity risks for Sun Pharmaceutical Industries Limited and 1 for Torrent Pharmaceuticals Limited.

Based on filings for periods ending 31 Mar 2026 (SUNPHARMA.NS) and 31 Mar 2026 (TORNTPHARM.NS) · Updated

FisclearScore Comparison

SUNPHARMA.NS68Strong
TORNTPHARM.NS66Strong
Quality+20
94
74
Efficiency+2
62
60
Value+10
62
52
Cashflow+20
56
76
Regime
55
55
Peers+6
70
76

FisclearScore is a quantitative model. SUNPHARMA.NS shown solid · TORNTPHARM.NS shown dashed. Not financial advice.

MetricSUNPHARMA.NSTORNTPHARM.NS
Price₹1,772.00₹4,632.70
Market Cap₹4.25T₹1.76T
P/E (TTM)35.2x72.5x
P/B5.1x18.7x
Beta0.140.14
Div Yield0.91%0.81%
Revenue (TTM)₹582.2B₹137.5B
Net Income₹114.8B₹21.6B
Gross Margin77.4%74.4%
Risk Flags—1 flag
Full SUNPHARMA.NS Report →Full TORNTPHARM.NS Report →

Related comparisons

Dr. Reddy's Laboratories vs Sun PharmaceuticalCIPLA.NS vs Sun PharmaceuticalDIVISLAB.NS vs Sun PharmaceuticalAPOLLOHOSP.NS vs Sun PharmaceuticalDr. Reddy's Laboratories vs TORNTPHARM.NSCIPLA.NS vs TORNTPHARM.NS

Data sourced from SEC EDGAR, Yahoo Finance, and official exchange filings. For informational purposes only. Not financial advice.